CereVasc Announces $70 Million Series B Financing Co-Led by Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund
Amount Raised
$70 Million
Round Type
Series B
BostonBiotechnologyInvestors
Description
CereVasc, Inc. has successfully completed the initial closing of a $70 Million Series B financing led by Bain Capital Life Sciences and existing investor Perceptive Xontogeny Venture Fund (PXV). The proceeds will support the clinical and regulatory development of CereVasc's eShunt System, including its upcoming STRIDE pivotal study in patients with Normal Pressure Hydrocephalus.
Quick answer
CereVasc raised $70 Million in a Series B round, dated May 13, 2024. Investors: Perceptive Xontogeny Venture Fund and Bain Capital Life Sciences. CereVasc is based in Boston, Massachusetts, United States.
- How much did CereVasc raise?
- CereVasc raised $70 Million in a Series B round on May 13, 2024.
- Who invested in CereVasc?
- Perceptive Xontogeny Venture Fund and Bain Capital Life Sciences are named as investors in this round.
- What does CereVasc do?
- Located in Massachusetts’ healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases.
- Where is CereVasc based and how big is it?
- CereVasc is based in Boston, Massachusetts, United States.
- Who are the decision-makers at CereVasc?
- Fundz holds 2 contacts at CereVasc, including the Senior Director, Marketing & Communications. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as CereVasc that raised within 45 days of this round, from Fundz verified event records.
- Climb Bio, Inc. raised $42M on June 27, 2024.
- EPICYPHER raised $3.3M on June 27, 2024.
- Holoclara raised $16M (Series A) on June 27, 2024.
- Climb Bio, Inc. raised $120M on June 27, 2024.
- Vertus Energy raised $9.5M (Seed) on June 27, 2024.
- CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
Who to call at CereVasc, and when
A new round usually means CereVasc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CereVasc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CereVasc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CereVasc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CereVasc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCereVasc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.